12.19.13
San Francisco, Calif.-based Genstar Capital Management LLC, a middle market private equity firm that focuses on investments in selected segments of the industrial technology, healthcare, financial services, and software industries, has acquired Tecomet Inc., a precision contract manufacturer supporting the medical device among other industries. Tecomet was previously a portfolio company of Charlesbank Capital Partners.
Founded in 1964 and based in Wilmington, Mass., Tecomet manufactures orthopedic implants, precision surgical instruments, trauma plates and photochemical etched products for medical device customers. Tecomet uses its prototyping and engineering capabilities to produce complex products.
Genstar will partner with the Tecomet management team including CEO Bill Dow and Chief Financial Officer John Connolly to continue the company’s impressive growth trajectory.
“Tecomet has become a trusted partner for our customers by providing differentiated manufacturing capabilities combined with industry-leading quality and reliability,” said Dow. “We look forward to our partnership with Genstar as we share a similar vision towards continuing Tecomet’s growth both organically and through acquisitions. Genstar has a proven track record of growing companies in the industrial and healthcare industries and we are excited to utilize their capital, expertise and network to help Tecomet accelerate its growth.”
“Tecomet is led by an outstanding management team that we are excited to partner with,” said Rob Rutledge, principal at Genstar. “Bill Dow, John Connolly and the rest of Tecomet’s employees have built the company into one of the premier precision manufacturers for the medical device and aerospace & defense industries, driving growth both organically and through the sourcing and integration of strategic acquisitions. Genstar is eager to partner with the Tecomet management team to expand the company’s capabilities, product offering and geographic reach while continuing to provide excellent quality and service to its customers.”
Founded in 1964 and based in Wilmington, Mass., Tecomet manufactures orthopedic implants, precision surgical instruments, trauma plates and photochemical etched products for medical device customers. Tecomet uses its prototyping and engineering capabilities to produce complex products.
Genstar will partner with the Tecomet management team including CEO Bill Dow and Chief Financial Officer John Connolly to continue the company’s impressive growth trajectory.
“Tecomet has become a trusted partner for our customers by providing differentiated manufacturing capabilities combined with industry-leading quality and reliability,” said Dow. “We look forward to our partnership with Genstar as we share a similar vision towards continuing Tecomet’s growth both organically and through acquisitions. Genstar has a proven track record of growing companies in the industrial and healthcare industries and we are excited to utilize their capital, expertise and network to help Tecomet accelerate its growth.”
“Tecomet is led by an outstanding management team that we are excited to partner with,” said Rob Rutledge, principal at Genstar. “Bill Dow, John Connolly and the rest of Tecomet’s employees have built the company into one of the premier precision manufacturers for the medical device and aerospace & defense industries, driving growth both organically and through the sourcing and integration of strategic acquisitions. Genstar is eager to partner with the Tecomet management team to expand the company’s capabilities, product offering and geographic reach while continuing to provide excellent quality and service to its customers.”